Literature DB >> 24319247

Optimal trauma resuscitation with plasma as the primary resuscitative fluid: the surgeon's perspective.

John B Holcomb1, Shibani Pati.   

Abstract

Over the past century, blood banking and transfusion practices have moved from whole blood therapy to components. In trauma patients, the shift to component therapy was achieved without clinically validating which patients needed which blood products. Over the past 4 decades, this lack of clinical validation has led to uncertainty on how to optimally use blood products and has likely resulted in both overuse and underuse in injured patients. However, recent data from both US military operations and civilian trauma centers have shown a survival advantage with a balanced transfusion ratio of RBCs, plasma, and platelets. This has been extended to include the prehospital arena, where thawed plasma, RBCs, and antifibrinolytics are becoming more widely used. The Texas Trauma Institute in Houston has followed this progression by putting RBCs and thawed plasma in the emergency department and liquid plasma and RBCs on helicopters, transfusing platelets earlier, and using thromboelastogram-guided approaches. These changes have not only resulted in improved outcomes, but have also decreased inflammatory complications, operations, and overall use of blood products. In addition, studies have shown that resuscitating with plasma (instead of crystalloid) repairs the "endotheliopathy of trauma," or the systemic endothelial injury and dysfunction that lead to coagulation disturbances and inflammation. Data from the Trauma Outcomes Group, the Prospective Observational Multicenter Major Trauma Transfusion (PROMMTT) study, and the ongoing Pragmatic Randomized Optimal Platelet and Plasma Ratios (PROPPR) trial represent a decade-long effort to programmatically determine optimal resuscitation practices, balancing risk versus benefits. With injury as the leading cause of death in patients age 1 to 44 years and hemorrhage the leading cause of potentially preventable death in this group, high-quality data must be obtained to provide superior care to the civilian and combat injured.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24319247     DOI: 10.1182/asheducation-2013.1.656

Source DB:  PubMed          Journal:  Hematology Am Soc Hematol Educ Program        ISSN: 1520-4383


  31 in total

1.  Transfusion of plasma, platelets, and red blood cells in a 1:1:1 vs a 1:1:2 ratio and mortality in patients with severe trauma: the PROPPR randomized clinical trial.

Authors:  John B Holcomb; Barbara C Tilley; Sarah Baraniuk; Erin E Fox; Charles E Wade; Jeanette M Podbielski; Deborah J del Junco; Karen J Brasel; Eileen M Bulger; Rachael A Callcut; Mitchell Jay Cohen; Bryan A Cotton; Timothy C Fabian; Kenji Inaba; Jeffrey D Kerby; Peter Muskat; Terence O'Keeffe; Sandro Rizoli; Bryce R H Robinson; Thomas M Scalea; Martin A Schreiber; Deborah M Stein; Jordan A Weinberg; Jeannie L Callum; John R Hess; Nena Matijevic; Christopher N Miller; Jean-Francois Pittet; David B Hoyt; Gail D Pearson; Brian Leroux; Gerald van Belle
Journal:  JAMA       Date:  2015-02-03       Impact factor: 56.272

2.  Making thawed universal donor plasma available rapidly for massively bleeding trauma patients: experience from the Pragmatic, Randomized Optimal Platelets and Plasma Ratios (PROPPR) trial.

Authors:  Deborah J Novak; Yu Bai; Rhonda K Cooke; Marisa B Marques; Magali J Fontaine; Jerome L Gottschall; Patricia M Carey; Richard M Scanlan; Eberhard W Fiebig; Ira A Shulman; Janice M Nelson; Sherri Flax; Veda Duncan; Jennifer A Daniel-Johnson; Jeannie L Callum; John B Holcomb; Erin E Fox; Sarah Baraniuk; Barbara C Tilley; Martin A Schreiber; Kenji Inaba; Sandro Rizoli; Jeanette M Podbielski; Bryan A Cotton; John R Hess
Journal:  Transfusion       Date:  2015-03-30       Impact factor: 3.157

3.  Pre-trauma center red blood cell transfusion is associated with improved early outcomes in air medical trauma patients.

Authors:  Joshua B Brown; Jason L Sperry; Anisleidy Fombona; Timothy R Billiar; Andrew B Peitzman; Francis X Guyette
Journal:  J Am Coll Surg       Date:  2015-01-24       Impact factor: 6.113

4.  Association of Prehospital Plasma Transfusion With Survival in Trauma Patients With Hemorrhagic Shock When Transport Times Are Longer Than 20 Minutes: A Post Hoc Analysis of the PAMPer and COMBAT Clinical Trials.

Authors:  Anthony E Pusateri; Ernest E Moore; Hunter B Moore; Tuan D Le; Francis X Guyette; Michael P Chapman; Angela Sauaia; Arsen Ghasabyan; James Chandler; Kevin McVaney; Joshua B Brown; Brian J Daley; Richard S Miller; Brian G Harbrecht; Jeffrey A Claridge; Herb A Phelan; William R Witham; A Tyler Putnam; Jason L Sperry
Journal:  JAMA Surg       Date:  2020-02-19       Impact factor: 14.766

5.  Mesenchymal stem cell-derived extracellular vesicles attenuate pulmonary vascular permeability and lung injury induced by hemorrhagic shock and trauma.

Authors:  Daniel R Potter; Byron Y Miyazawa; Stuart L Gibb; Xutao Deng; Padma P Togaratti; Roxanne H Croze; Amit K Srivastava; Alpa Trivedi; Michael Matthay; John B Holcomb; Martin A Schreiber; Shibani Pati
Journal:  J Trauma Acute Care Surg       Date:  2018-02       Impact factor: 3.313

6.  Pretrauma center red blood cell transfusion is associated with reduced mortality and coagulopathy in severely injured patients with blunt trauma.

Authors:  Joshua B Brown; Mitchell J Cohen; Joseph P Minei; Ronald V Maier; Michaela A West; Timothy R Billiar; Andrew B Peitzman; Ernest E Moore; Joseph Cuschieri; Jason L Sperry
Journal:  Ann Surg       Date:  2015-05       Impact factor: 12.969

7.  Exploring ethical conflicts in emergency trauma research: the COMBAT (Control of Major Bleeding after Trauma) study experience.

Authors:  Theresa L Chin; Ernest E Moore; Marilyn E Coors; James G Chandler; Arsen Ghasabyan; Jeffrey N Harr; John R Stringham; Christopher R Ramos; Sarah Ammons; Anirban Banerjee; Angela Sauaia
Journal:  Surgery       Date:  2014-10-14       Impact factor: 3.982

Review 8.  Hemorrhagic blood failure: Oxygen debt, coagulopathy, and endothelial damage.

Authors:  Nathan J White; Kevin R Ward; Shibani Pati; Geir Strandenes; Andrew P Cap
Journal:  J Trauma Acute Care Surg       Date:  2017-06       Impact factor: 3.313

9.  New low-volume resuscitation solutions containing PEG-20k.

Authors:  Dan Parrish; Valerie Plant; Susanne L Lindell; Ashley Limkemann; Heather Reichstetter; Michel Aboutanos; Martin J Mangino
Journal:  J Trauma Acute Care Surg       Date:  2015-07       Impact factor: 3.313

10.  A Potential Mechanism for Immune Suppression by Beta-Adrenergic Receptor Stimulation following Traumatic Injury.

Authors:  Nicholas J Shubin; Tam N Pham; Kristan Lea Staudenmayer; Brodie A Parent; Qian Qiu; Grant E O'Keefe
Journal:  J Innate Immun       Date:  2018-02-16       Impact factor: 7.349

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.